Skip to content
OpenCapital
Get started

Bicara Therapeutics BCAX Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
Corvex logo
Corvex MOVE
$899K+12.4%
Disc Medicine logo
Disc MedicineIRON
$2.17M+18.2%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.49M+25.5%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$18.67M-34.4%

Segments

By segment

See full
Reportable Segment$601K+8.1%

Other financials

Income statement

See full
Operating income-$60.2M-44.2%
Net income-$56.2M-52.6%
EPS (diluted)-$0.93-36.8%

Balance sheet

See full
Cash & equivalents$323.5M-30.0%
Total debt$1.4M+144%
Total equity$514.0M+12.0%
Total assets$553.6M+15.8%

Cash flow

See full
Operating cash flow-$37.5M-33.5%
CapEx$60.0K—
Free cash flow-$37.6M-33.7%

Valuation

See full
Market cap$1.68B+81.4%
Enterprise value$1.36B+288%

Returns & leverage

See full
Return on equity-32.3%—
Debt / equity0×0.0×
Current ratio13.9×-10.8×